MIRM · Healthcare · $5.2B
$84.91-0.67%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출 1억7,600만 달러로 전 분기 1억6,000만 달러에서 계속 가속됐어요.”
In the company's words · 2026 2분기 earnings call